6 news items
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
MRVI
18 Apr 24
experience, CDMO services, and high-quality readymade and custom materials, including its patented CleanCap® mRNA capping technology
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
BREA
CELZ
DIS
8 Mar 24
materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
ARDX
DYAI
MEDS
28 Feb 24
at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
MRVI
22 Feb 24
results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any
Earnings Scheduled For February 22, 2024
KYMR
L
LASR
22 Feb 24
to report earnings for its fourth quarter.
• MP Materials (NYSE:MP
niadawv5bg qwzmqvac
DYAI
MRVI
13 Feb 24
research projects and third-party collaborations, as well as the availability of necessary funding. Actual events or results may differ materially from those
- Prev
- 1
- Next